Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 17Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Osteosarcoma 1Neoplasm Metastasis 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Gastrointestinal Stromal Tumors 1Desmoid Tumors 1Carcinoma, Non-Small-Cell Lung 1Bone Neoplasms 1

Interventions

nirogacestat 8Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3Cryosurgery 3X-Rays 2Toremifene 2Phantoms, Imaging 2Blood Specimen Collection 2vactosertib 1trifluridine tipiracil drug combination 1strattice 1liposomal doxorubicin 1entinostat 1anlotinib 1Vinblastine 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiofrequency Ablation 1Pregnancy 1Oxaliplatin 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoid Tumors × anlotinib × Sarcoma × Clear all
NCT05490667 2023-10-30

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Henan Cancer Hospital

Phase NA Unknown
30 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡